Developing a Successful Biopharmaceutical Pricing & Market Access Strategy
Windrose Consulting Group collaborate with Cambridge University on a Executive education course on Pricing and Market Access Strategy.
Colin Banks, Anant Sriram and Georgia Schonberg promoted
We are delighted to announce the promotions of Colin Banks, Anant Sriram & Georgia Schonberg at Windrose Consulting Group. They have all been promoted to Senior Analyst roles.
Itamar Carrillo, joins the Windrose office in London
Windrose Consulting Group are pleased to welcome a new starter, Itamar Carrillo in our London office. Itamar has an extensive academic background.
New Starter in Luzern, Switzerland: Pamela Fetzer
Windrose Consulting Group are pleased to welcome a new starter, Pamela Fetzer in our Luzern, Switzerland office.
Switzerland Pricing and Reimbursement Market-System overview
Download the report to find out about the pharmaceutical pricing & reimbursement process in Switzerland including, Payer Evaluation, Price setting, Reimbursement and Cost containment.
Norway Pricing and Reimbursement Market-System overview
Download the report to find out about the pharmaceutical pricing & reimbursement process in Norway including, Payer Evaluation, Price setting, Reimbursement and Cost containment.
Denmark Pricing and Reimbursement Market-System overview
Download the report to find out about the pharmaceutical pricing & reimbursement process in Denmark, including, Payer Evaluation, Price setting, Reimbursement and Cost containment.
Canadian Pricing and Reimbursement Market-System overview
Download the report to find out about the Canadian pharmaceutical pricing & reimbursement process, including, Payer Evaluation, Price setting, Reimbursement and Cost containment.
Australian Pricing and Reimbursement Market-System overview
Download the report to find out about the Australian pharmaceutical pricing & reimbursement process, including, Payer Evaluation, Price setting, Reimbursement and Cost containment.
New Starters in London: Ioana Vitan and James O’Brien
Windrose Consulting Group are pleased to welcome two new starters, Ioana Vitan and James O’Brien into the London office.
Anjalina Mitra and Agatha Cimbalova promoted
Windrose are excited to announce two promotions in our London office. Anjalina Mitra and Agatha Cimbalova have both been promoted to Consultant, after making huge progress in their Senior Analyst roles.
Global News Roundup: Q3 2022
We are pleased to release the next edition of our Windrose Consulting Group: Global News Roundup for Q3 2022.
Q&A – with Jude Baroudi , Analyst at Windrose
In this Q&A, we are featuring Jude Baroudi and his career journey and highlights to date.
Five New Starters in the US
Windrose Consulting Group are pleased welcome five new starters, Paige Stitzel, Steven Lin, James Fay, Adrian Jung and Ilana Price, into the Philadelphia office.
New Starters in London: Joana Lama and Kristina Funk
Windrose Consulting Group are pleased welcome two new starters, Joana Lama and Kristina Funk into the London office.
Commercial Health Insurances as an access route to the Chinese market
In an article, published on Pharmexec, Anaïs Frappé, Amy Morgan and Crystal Leung, review market access opportunities in China through private payers, and how Commercial Health Insurance (CHI) can bring value before, during, and after NRDL inclusion.
Georgina Powell and Kate Hogan promoted
Windrose are thrilled to announce two key promotions in our London office. Georgina Powell has been promoted to from Senior Analyst to Consultant and Kate Hogan from Senior Consultant to Engagement Manager.
Inflation Reduction Act: Implications for US Healthcare and Pharmaceutical Industries
On August 16th, 2022, President Biden signed the Inflation Reduction Act into law, which will bring reforms to Medicare spending and coverage, impacting manufacturers’ long-term P&MA strategy and payer decision-making.
The Foreign Data Problem: Implications of the FDA’s New Criteria for Foreign Data Submissions
Windrose Consulting Group’s take on The Foreign Data Problem: Implications of the FDA’s New Criteria for Foreign Data Submissions.
Global News Roundup: Q2 2022
We are pleased to release the next edition of our Windrose Consulting Group: Global News Roundup for Q2 2022.